BioRay's ROR1-Targeting Dual-Epitope ADC Drug BR111 Receives Formal Clinical Trial Approval from NMPA SHANGHAI, Feb. 10, 2025 /PRNewswire/ — On December 19, 2024, BioRay Pharmaceutical… CISION PRNewswireFebruary 10, 2025
Meeting Australia's Growing Demand for Sustainable Tissue Products: APP Group and Sorbent Paper Lead the Charge JAKARTA, Indonesia, Feb. 10, 2025 /PRNewswire/ — Consumer demands in Australia have… CISION PRNewswireFebruary 10, 2025
Press ReleaseAddress Advisors Setting Benchmarks for GCC's Real Estate Solutions in India SINGAPORE and BENGALURU, India, Feb. 10, 2025 /PRNewswire/ — Address Advisors, a… CISION PRNewswireFebruary 10, 2025
Caliway Announces CBL-514 Second Phase 2b Study Results (CBL-0205) Met Endpoints CBL-514, the world’s first investigational drug for large-area localized fat reduction, has… CISION PRNewswireFebruary 10, 2025
Press ReleaseFOUR POINTS BY SHERATON BINTAN, LAGOI BAY CELEBRATES GRAND OPENING, INVITES GUESTS TO FULLY EXPERIENCE THE STUNNING BEAUTY OF BINTAN ISLAND Embracing a harmonious blend of comfort and contemporary elegance,the first Four Points… CISION PRNewswireFebruary 10, 2025
NX Hong Kong Receives Environmental Management, Occupational Health/Safety Management System Certifications – Integrated Quality, Environmental and Safety Management Systems Now in Place –… CISION PRNewswireFebruary 10, 2025
Line Inspectors: Treading the Mountain, Crossing the Snow To Guarantee the Power Supply SHIHEZI, China, Feb. 10, 2025 /PRNewswire/ — On February 4th, the seventh… CISION PRNewswireFebruary 10, 2025
First Hong Kong Trader Wins the US Investing Championship! From Teacher to Trading Pro–J Law Achieves Over 353% Annual Return, Breaking Global Records HONG KONG, Feb. 10, 2025 /PRNewswire/ — Law Wai-Sum (A.K.A. J Law)… CISION PRNewswireFebruary 10, 2025
